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ABSTRACT
Systemically administered human recombi-
nant erythropoietin (EPO) may have the po-
tential to reduce the cognitive and behavioral
symptoms of mechanical brain injury. In a
series of studies, we address this possibility. We
previously found that EPO given to fimbria-
fornix transected rats at the moment of injury
could substantially improve the posttraumatic
acquisition of an allocentric place learning task
when such a task is administered in a water
maze. Due to the clinical importance of such
results, it is important to scrutinize whether the
therapeutic effect of EPO is specific to the
experimental setup of our original experiments
or generalizes across test situations. Conse-
quently, here we studied the effects of similarly
administered EPO in fimbria-fornix transected
and control operated rats, respectively, evalu-
ating the posttraumatic behavioral/cognitive
abilities in an allocentric place learning task
administered in an 8-arm radial maze. The
administration of EPO to the hippocampally
injured rats was associated with a virtually
Reprint requests to: Jesper Mogensen, The Unit for Cog-
nitive Neuroscience, Department of Psychology, University of
Copenhagen, Oester Farimagsgade 5 A, Building 10, DK-
1353 Copenhagen K, Denmark; e-mail: jesper.mogensen@
psy.ku.dk
complete elimination of the otherwise severe
behavioral impairment caused by fimbria-fornix
transection. In contrast, EPO had no detectable
effect on the task acquisition of non-lesioned
animals. The results of the present study confirm
our previous demonstration of EPO’s ability to
reduce or eliminate the behavioral/cognitive
consequences of mechanical injury to the
hippocampus, while adding the important
observation that such a therapeutic effect is not
restricted to the specific experimental setup
previously studied.
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INTRODUCTION
Specific receptors for erythropoietin (EPO), a
hormone that also stimulates the body to produce
red blood cells, have been found on neurons, glial
cells, and brain capillary endothelial cells
(Bernaudin et al., 1999; Brines et al., 2000; Juul et
al., 1998; Masuda et al., 1993; Morishita et al.,
1997; Yamaji et al., 1996). Neurons, as well as
astrocytes, produce EPO in an oxygen-dependent
manner (Bernaudin et al., 2000; Chin et al., 2000;
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Digicaylioglu et al., 1995; Marti et al., 1996;
Masuda et al., 1994; Tan et al., 1992). Such results
have in recent years led to a dramatic increase in
the interest in the potential neuroprotective roles
of EPO (for reviews see e.g., Buemi et al., 2002;
Dame et al., 2001; Olsen, 2003). It has even been
suggested that EPO might be able to act
therapeutically in patients suffering certain
neurodegenerative conditions (e.g., Ehrenreich et
al, 2004). A number of studies (for references, see
below) have demonstrated that EPO may be able
to act therapeutically in case of various types of
brain injury. Peripherally administered human
recombinant EPO penetrates the blood-brain
barrier and can exert neuroprotective effects in
case of both brain ischemia and experimental
subarachnoid hemorrhage (e.g., Alafaci et al.,
2000; Brines et al., 2000; Buemi et al., 2000;
Calapai et al., 2000; Grasso 2001; Siren et al.,
2001; Springborg et al., 2002). The
neuroprotective potentials of EPO have been
demonstrated mainly in animal models of various
types of vascular incidents (e.g., Alafaci et al.,
2000; Brines et al., 2000; Buemi et al., 2000;
Calapai et al., 2000; Grasso 2001; Siren et al.,
2001; Springborg et al., 2002). It is clear, however,
that EPO even has the potential of exerting such
effects in case of nonvascular types of neural
trauma. For instance, EPO increases the survival
of septal cholinergic neurons in rats subjected to
transection of the fimbria-fomix (Konishi et al.,
1993) and protects against the neurotoxicity of
MPTP (Genc et al., 2001). Additionally, EPO
modifies the consequences of spinal cord injury
(e.g., Celik et al., 2002; Gorio et al., 2002; Iwasaki
et al., 2002), kainate-induced seizures (Brines et
al., 2000), and blunt trauma (Brines et al., 2000).
Most studies addressing the potentially thera-
peutic effects of EPO after brain injury evaluated
such effects by utilizing histological and/or
neurochemical methods exclusively. Only a few
studies have addressed the question whether the
administration of EPO also improves the post-
traumatic behavioral and cognitive outcome after a
given lesion. Until recently, the rare studies
dealing with this issue (e.g., Catania et al., 2002;
Kumral et al., 2004; Sadamoto et al., 1998) have
exclusively used animal models of various
vascular types of brain injury. Recently, however,
we addressed the issue of whether EPO can
improve the posttraumatic cognitive/behavioral
performance of mechanically brain injured rats.
We did so by studying the posttraumatic acqui-
sition of a water maze-based allocentric place
learning task of the mapping type after transection
of the fimbria-fomix. Such a task is known to be
highly sensitive to hippocampal dysfunction (e.g.,
Cassel et al., 1998; DiMattia & Kesner, 1988;
Hannesson & Skelton, 1998; Mogensen et al.,
2004a; Morris et al., 1982; Morris et al., 1986;
Packard& McGaugh, 1992; Sutherland& Rodriguez,
1989; Sutherland et al., 1982; Sutherland et al.,
1983; Whishaw & Jarrard, 1995; Whishaw et al.,
1995). We have by now repeatedly (Mogensen et
al., 2004b; Mogensen et al., submitted) demon-
strated that systemically administered EPO can
improve a water maze-based place learning task in
fimbria-fomix transected subjects, thereby showing
an ability to support posttraumatic behavioral/
cognitive recovery.
The ability of systemically administered EPO
to reduce the cognitive/behavioral consequences of
hippocampal injury and/or significantly support
the posttraumatic functional recovery after such
lesions is of substantial clinical importance. It
should, however, be noticed that to evaluate the
therapeutic potentials of EPO, it is necessary to
further scrutinize the generality of such EPO-
associated effects. As emphasized elsewhere (e.g.,
Mogensen, 2003) one frequently encounters a sur-
prisingly high degree of method dependency when
evaluating the consequences of brain injury and/or
pharmacological interventions. For instance, the
interhemispheric transfer of information relevant to
the performance of a visual discrimination task in
cats subjected to transections of callosal connectionsERYTHROPOIETIN AND PLACE LEARNING 331
appear to be possible when tested in a Lashley-
type jumping stand but absent when tested in a
classic two-choice discrimination box (Lepore et
al., 1985). Additionally, rats subjected to lesions
within the prefrontal system are severely impaired
in a spatial delayed alternation task when tested in
a T-maze but perform at a normal proficiency
when encountering the same task in an operant
chamber (Mogensen et al., 1987). As a final
example, until we realized the differentiation
between allocentric place learning tasks of the
mapping and non-mapping types (e.g., Mogensen
et al., 1995b; 2002; 2004a; W6rtwein et al., 1995)
differential setups of water mazes might result in
contradictive results of brain injury or pharma-
cological manipulation. Compare for instance the
consequences of hippocampal lesions in Mogensen
et al. (2004a) and W6rtwein et al. (1995).
Consequently, the ability of EPO to counteract the
posttraumatic impairment of allocentric place
learning demonstrated so far in water mazes
(Mogensen et al, 2004b; Mogensen et al.,
submitted) should also be evaluated in a different
experimental setup. We therefore decided to test
whether systemically administered EPO can
reduce the behavioral/cognitive consequences of
fimbria-fomix transections, even when the post-
traumatic acquisition of an allocentric place
learning task is tested in an 8-arm radial maze.
Lesions of the hippocampus, including transections
of the fimbria-fomix, have been shown to be
associated with impairments of allocentric place
learning when tested in 8-arm radial mazes (Cassel
et al., 1998).
For the present study, we chose to repeat our
original design, in which two groups of rats were
subjected to transections of the fimbria-fomix.
One group was administered EPO at the moment
of injury, whereas the other group received control
injections of saline (vehicle); two groups were
subjected to sham surgery and received pharma-




Thirty-six experimentally naive, male Wistar
albino rats with an initial body weight of
approximately 300 g each served as subjects. The
animals were housed two per cage with water
always available in a colony room with a 12 h light
cycle (on at 6.00h). The animals were fed
commercial rat chow once daily after training and
were maintained at approximately 85% of their ad
libitum body weights. The rats were randomly
divided into four experimental groups:
1. sham surgery accompanied by a saline
(vehicle) control injection (Sham/Sal) (n=7),
2. sham surgery accompanied by injection of
EPO (Sham/EPO) (n 10 ),
3. bilateral transection of the fimbria-fornix
accompanied by saline (vehicle) control
injection (FF/Sal) (n=9), and
4. bilateral transection of the fimbria-fomix
accompanied by injection of EPO (FF/EPO)
(n=10).
The experimental protocol was approved by
the Danish National Review Committee for the use
of Animal Subjects ("Dyreforsogstilsynet"). All
procedures were in compliance with the European
Communities Council Directive of 24 November
1986 (86/609/EEC).
Apparatus
All training and testing was performed in an
open, black, one-unit 8-arm radial maze with
2.7 cm high walls and 9.2 cm wide corridors. The
8arms radiated equidistantly from a circular
central area with a diameter of 50.0 cm. Each arm
was 60.0 cm long, and at the end of the arm a
circular food well (diameter: 4.8cm depth:
2.3 cm) contained the reinforcements in the form332 HANAMAL ET AL.
of 45 mg food pellets (Precision Food Pellets of
Campden Instruments, England). The maze was
placed in the centre of a well lit room, in which no
other animals were present during training and
testing, and in which a multitude of two as well as
three dimensionally arranged distal cues were
available.
Behavioral procedures
Preoperatively all animals were habituated to
the maze and shaped. The habituation lasted for
two sessions. Each session allowed the rats 25 min
of undisturbed exploration of the maze. During the
first habituation session, 45-mg reinforcement
pellets were scattered all over the maze, whereas
in the second habituation session, the reinforce-
ment pellets were present only in and around the
food wells. In the third session, the shaping
procedure was initiated. During shaping, 15 trials
(runs) were given per (daily) session, and the start
arm of each trial was randomly selected. The
reinforcement pellets were present in the food
wells of all arms but the start arm, and the animal
was released from the end of the start arm. After
reaching the end of any of the response arms, the
animal was allowed to eat freely four reinforce-
ment pellets. Subsequently, the animal was picked
up and the next trial initiated. The shaping
procedures continued until all animals promptly
(within less than 10 s) entered one of the response
arms when released. The postoperative behavioral
procedures were initiated 6 or 7 days after surgery.
During the first three postoperative sessions, the
animals were briefly reshaped. In the fourth
postoperative session, training and testing of the
place learning task was initiated. All animals were
given one daily place learning session on 20
consecutive days. At each acquisition session, 15
trials (runs) were given and 4 reinforcement pellets
were present in all arms but the start arm. One arm
(defined according to its spatial location within the
experimental room) was defined as the goal arm
for all trials throughout the task acquisition period.
The remaining seven arms served as (for each trial
randomly selected) start arms. To avoid the
possibility of succezl task solution being based
on local (intramaze) cues, we rotated the maze
between sessions (in such a way that only the
spatial position but not the intramaze identity of
the goal arm remained constant between sessions).
When entering the goal arm, the rat was allowed to
reach the food well and consume the four
reinforcement pellets. If, however, an incorrect
arm was entered, the animal was picked up before
reaching the food well and returned to a holding
cage where it remained until the next trial. After a
correct trial, the animal was likewise transferred to
a holding cage until the next trial. The inter-trial
periods were of approximately min duration.
From each trial, two parameters were recorded: the
total number of errors and the number of "distal"
errors (defined as all errors but those to the two
arms adjacent to the goal arm). Although all
animals continued behavioral training and testing
for all 20 task acquisition sessions, when an
animal reached a behavioral criterion defined as
two consecutive days with no errors, this was
recorded.
Statistical analysis
Non-parametric statistics were chosen because
the normal distribution of Behavioral data could
not be expected, and the sample sizes were too
small for the proper testing of the underlying
distributions (Pett, 1997). The Kruskal-Wallis non-
parametric analysis of variance was initially
performed (Siegel, 1956). If the analysis of
variance revealed significant group differences,
then Mann-Whitney U-tests were applied (Siegel,
1956). The latter were two-tailed, except for the
analysis comparing the quality oftask performance
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predicted impairment in the lesioned group
allowed the use of a one-tailed analysis. The two
parameters from all sessions, as well as the number
of sessions required to reach the Behavioral
criterion, were analyzed in this manner (in case an
animal failed to reach the Behavioral criterion
within the 20 sessions, the "number of sessions to
criterion" was indicated as 21).
Surgery and administration ofEPO
Surgery (which lasted approximately 30 min per
animal) was performed with the aid of a surgical
microscope under clean but non-sterile conditions.
The animals were anesthetized by intraperitoneal
injection of Equithesin (3.3 ml/kg body weight) and
1% Atropin sulphate (0.9mg/kg body weight).
Bilateral transections of the fimbria-fomix were
performed stereotaxically using a wire-knife. Detailed
descriptions of the surgical procedures have
previously been published (e.g., Mogensen et al.,
2004a; 2004b; 2005).
Simultaneously with the performance of
surgery, all animals received one intraperitoneal
injection in a volume of 1.0 mL, either a vehicle
(saline) injection or an administration of EPO
(EprexTM, 10,000 IU/ml, Janssen-Cilag, Denmark)
in the dosage of 5,000 IU/kg body weight.
Histology
After the completion of the Behavioral testing,
all animals were deeply anesthetized (Equithesin
injection) and transcardially perfused with saline,
followed by 10% formalin in saline solution. After
perfusion, the brains were removed and allowed to
sink at 4C in 10% formalin in saline solution
containing 20% sucrose. The brains were cut
horizontally at 50 l.tm on a vibratome. The Nissl-
stained sections were examined with the help of a




Histological examination of the fimbria-fomix
transected brains established that all lesioned
animals had transections of the major portion of
this fiber bundle, although a minor portion of the
fibers of the fimbria-fomix remained intact. Only
minor variations between the extents of lesion in
individual animals were apparent, and the lesions
of the fimbria-fomix-transected groups were of
similar extem.
Behavior
The Behavioral results are illustrated in Figs.
and 2. As shown in Fig. 1, the fimbria-fomix tran-
sected group receiving saline injections (FF/Sal)
required significantly more sessions to reach the
Behavioral criterion when compared with the
Sham/Sal, as well as with the FF/EPO groups. The
fimbria-fomix-transected EPO-treated group, on
the other hand, fulfilled the Behavioral criterion as
quickly as the two control-operated groups did.
Administration of EPO to sham-operated control
animals did not significantly influence the number
of sessions required to fulfill the criterion. For this
parameter, the analysis of variance was significant
at the p < 0.01 level. The levels of significance for
the individual group comparisons are given in
Fig. (note that the indicated values are medians
and ranges). Although the distance between
minimum and maximum values differ somewhat
between groups, the general variability does not
differ to any major extent.
As reflected in the learning curves illustrated
in Fig. 2, the fimbria-fomix transected saline
injected (FF/Sal) group demonstrated a certain
level of Behavioral recovery in the form of gradual
task acquisition, but remained significantly
impaired when compared to both the saline
injected sham operated group (Sham/Sal) and the334 HANA MAL/ ET AL.
21-
14-
Sham/Sal Sham/EPO FF/Sal FF/EPO
Fig. 1" Number of sessions required by the four experimental groups to reach the task acquisition criterion (see
Experimental section for details). Values are given as medians with ranges. **" Significantly (p < 0.01) different
from the Sham/Sal group, x: Significantly (p < 0.05) different from the FF/EPO group.
EPO-treated fimbria-fornix transected group
(FF/EPO) throughout most of the 20 d of the task
acquisition period. In contrast, neither the FF/
EPO group nor the Sharn/EPO group differed
significantly from the normal animals of the
Sharn/Sal group throughout the task acquisition
period. For the total number of errors, the analysis
of variance indicated the presence of significant
group differences on the following sessions:
Total errors
session 3 (p < 0.05) session 13 (p < 0.05)
session 4 (p < 0.01) session 14 (p < 0.05)
session 5 (p < 0.01) session 15 (p < 0.001)
session 6 (p < 0.05) session 16 (p < 0.05)
session 10 (p < 0.05) session 18 (p <0.001)
session 11 p < 0.001) session 19 (p < 0.01)
For the number of "distal" errors, the analysis of
variance indicated the presence of significant









For both parameters, the levels of significance for
the individual group comparisons are given in
Fig. 2.
DISCUSSION
The results of the present study (Figs. and 2)
clearly demonstrate that systemically admini-
stered human recombinant EPO can dramatically
improve the cognitive/behavioral performance of
rats after mechanical brain injury in the form of
bilateral transections of the fimbria-fornix.
Although we previously demonstrated such an
ability in the form of complete or near-completeERYTHROPOIETIN AND PLACE LEARNING 335
Session
Fig. 2: Performance of the four experimental groups (black square and solid line: Sham/Sal; black triangle and solid
line: FF/Sal; open square and broken line: Sham/EPO; open triangle and broken line: FF/EPO) on the
20 sessions ofthe place learning acquisition period. Values are given as medians. *: Significantly (p<0.05)
different from the Sham/Sal group. (*): Significantly (p<0.05, one-tailed) different from the Sham/Sal group.
**: Significantly (p<0.01) different from the Sham/Sal group, x: Significantly (p<0.05) different from the
FF/EPO group, xx: Significantly (p<0.01) different from the FF/EPO group.336 HANA MAL/i ET AL.
normalization of post-traumatic acquisition of a
water maze-based allocentric place learning task
(Mogensen et al., 2004b; Mogensen et al.,
submitted), in the present study we obtained a
similar effect in an allocentric place learning task
performed in a completely different experimental
setup--an 8-arm radial maze.
As expected (Cassel et al., 1998), the saline
injected fimbria-fomix-transected group had a
significantly impaired acquisition of the 8-arm
radial maze-based allocentric place learning task.
Even this group, however, eventually managed to
acquire the task to a relatively high proficiency of
task performance, thereby demonstrating a
functional recovery (Fig. 2). In contrast, .the
similarly lesioned group treated with EPO at the
moment of brain injury did not differ significantly
from the saline-injected, sham-operated control
group. Consequently, it has to be concluded that
EPO can either completely eliminate the normally
occurring negative consequences of the fimbria-
fornix transections or promote compensational
processes, which were so immediate that even
initial behavioral symptoms could not be observed.
(See for instance Mogensen et al., 2002, for an
example of immediate and complete compensation
for the consequences of a neural disturbance
preventing even initial behavioral symptoms.)
The two sham-operated groups receiving
saline control injections and systemic injections of
EPO, respectively, did not differ significantly on
any behavioral measure (Figs. 1-2). Consequently,
it has to be concluded that when administered in
one high dose 6 or 7 days before the initiation of
training on the presently studied type of place
learning, EPO does not influence the performance
of the task either negatively or positively. This
result seems to be in agreement with the results of
Hengemihle et al. (1996), who found an improved
quality of place learning in a water maze in non-
lesioned EPO treated animals after 19 wk ofEPO
administration every other day, but absence of
such an effect after 8 wk of a similar treatment
regime. On the background of such results, one
would not expect the task performance of intact
animals to be influenced by the presently studied
administration of EPO. In two previous studies,
however, we found EPO, administered as in the
present study, to influence place learning of intact
rats in a water maze. In our initial study (Mogensen
et al., 2004b) animals treated in this way displayed
a modified search pattern but no change in the
quality of task performance, whereas subsequently
(Mogensen et al., submitted) we found a minor
but significant impairment of the task perfor-
mance of EPO-treated, non-lesioned rats. On the
other hand, EPO has been suggested to act as a
"cognitive enhancer" in normal animals (see for
instance Ehrenreich et al., 2004, for a suggestion
of such a role for this hormone). Our three studies
of allocentric place learning in EPO-treated sham
operated animals (Mogensen et al., 2004b; Mo-
gensen et al., submitted; and present results) do
not lend support to such a notion however.
As we have previously emphasized (Mogensen
et al., 2004b; Mogensen et al., submitted), EPO-
associated improvements of posttraumatic
Behavioral/cognitive performance in lesioned
individuals can be, in principle, obtained via one
or both oftwo categories ofmechanisms:
1. The magnitude of injury inflicted on the
neural substrate of the normally employed
task solution can be reduced by EPO ad-
ministration. In the case of tasks like that
currently studied here, which normally rely
heavily upon hippo-campal contributions to
task mediation, it may be of relevance that
Konishi et al. (1993) found an increased
survival of septal cholinergic neurons after
transections ofthe fimbria-fornix.
2. Erythropoietin can facilitate a process in
which the task is mediated by an alternative
neural substrate (e.g., Mogensen & Holm, 1994;
Mogensen et al., 1995a-d; 1996; 2002; 2004a;
2005). Such an EPO-associated facilitation of
the neural reorganizations that are necessaryERYTHROPOIETIN AND PLACE LEARNING 337
for the application of an alternative solution
strategy can, for instance, be obtained by
facilitating synaptic plasticity--e.g., via an
effect on Ca2+ channels and the NO system
(Assandri et al., 1999; Koshimura et al.,
1999; Miller et al., 1999), or synaptic trans-
mission (Weber et al., 2002). Erythropoietin
might also protect significant parts of the
neural substrate of alternative behavioral
strategies by diminishing or eliminating the
secondary or tertiary consequences of the
primary neural trauma. This task might be
accomplished, for instance, via the ability of
EPO to increase the activity of antioxidant
enzymes (Chattopadhyay et al., 2000;
Sakanaka et al., 1998; Sela et al., 2001),
thereby acting as an indirect free radical
scavenger.
By addressing some cognitive mechanisms of
EPO-assisted posttraumatic recovery after fimbria-
fornix transections, we found indications that
with at least some administration schedules and
certain tasks, EPO facilitates the application of an
alternative solution strategy rather than preserving
one identical to that applied by normal animals
(Mogensen et al., submitted). In the same study,
however, we also saw indications that this might
not be the only mechanism via which EPO
improves the posttraumatic functional recovery of
a place learning task.
The results of the present study do not point
directly to one or the other of these therapeutic
mechanisms of EPO. We have now clearly
established, however, that the EPO-associated
dramatic improvement of allocentric place
learning in fimbria-fornix transected rats is not
specific to such tasks administrated in a water
maze. Presently, a cognitively rather similar task
was administered in a setup requiring not only
motoric responses clearly different from those of
a rat swimming in a water maze but also
presumably solution strategies somewhat dissimilar
to those applicable in the previously studied,
experimental setups. Yet, the administration of
EPO to fimbria-fornix-transected rats led to a
virtual elimination of the lesion-associated task
impairment. Whether obtained via one or the
other of the two above mentioned classes of
hormonal action, the results clearly testify that
administration of human recombinant EPO is
likely to have cognitive/behavioral therapeutic
effects, which even in case of mechanical brain
injury, can be effective across the situations in
which a particular neural/cognitive mechanism is
required.
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